285 related articles for article (PubMed ID: 33228195)
1. Aerobic Cytotoxicity of Aromatic
Nemeikaitė-Čėnienė A; Šarlauskas J; Misevičienė L; Marozienė A; Jonušienė V; Lesanavičius M; Čėnas N
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228195
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of Flavoenzyme-Catalyzed Reduction of Tirapazamine Derivatives: Implications for Their Prooxidant Cytotoxicity.
Nemeikaitė-Čėnienė A; Šarlauskas J; Jonušienė V; Marozienė A; Misevičienė L; Yantsevich AV; Čėnas N
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533349
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of RH1 and related aziridinylbenzoquinones: involvement of activation by NAD(P)H:quinone oxidoreductase (NQO1) and oxidative stress.
Nemeikaite-Ceniene A; Sarlauskas J; Anusevicius Z; Nivinskas H; Cenas N
Arch Biochem Biophys; 2003 Aug; 416(1):110-8. PubMed ID: 12859987
[TBL] [Abstract][Full Text] [Related]
4. Reactions of
Lesanavičius M; Aliverti A; Šarlauskas J; Čėnas N
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370303
[TBL] [Abstract][Full Text] [Related]
5. The study of NADPH-dependent flavoenzyme-catalyzed reduction of benzo[1,2-c]1,2,5-oxadiazole N-oxides (benzofuroxans).
Šarlauskas J; Misevičienė L; Marozienė A; Karvelis L; Stankevičiūtė J; Krikštopaitis K; Čėnas N; Yantsevich A; Laurynėnas A; Anusevičius Ž
Int J Mol Sci; 2014 Dec; 15(12):23307-31. PubMed ID: 25517035
[TBL] [Abstract][Full Text] [Related]
6. Effect of dicumarol, a Nad(P)h: quinone acceptor oxidoreductase 1 (DT-diaphorase) inhibitor on ubiquinone redox cycling in cultured rat hepatocytes.
Kishi T; Takahashi T; Mizobuchi S; Mori K; Okamoto T
Free Radic Res; 2002 Apr; 36(4):413-9. PubMed ID: 12069105
[TBL] [Abstract][Full Text] [Related]
7. Role of NADPH cytochrome P450 reductase in activation of RH1.
Begleiter A; Leith MK; Patel D; Hasinoff BB
Cancer Chemother Pharmacol; 2007 Oct; 60(5):713-23. PubMed ID: 17256129
[TBL] [Abstract][Full Text] [Related]
8. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
[TBL] [Abstract][Full Text] [Related]
9. Prooxidant cytotoxicity of chromate in mammalian cells: the opposite roles of DT-diaphorase and glutathione reductase.
Nivinskas H; Nemeikaite-Ceniene A; Maroziene A; Normantiene T; Cenas N
Z Naturforsch C J Biosci; 2006; 61(11-12):889-95. PubMed ID: 17294702
[TBL] [Abstract][Full Text] [Related]
10. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1.
Tan AS; Berridge MV
Free Radic Biol Med; 2010 Feb; 48(3):421-9. PubMed ID: 19932748
[TBL] [Abstract][Full Text] [Related]
11. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
Buranrat B; Prawan A; Kukongviriyapan U; Kongpetch S; Kukongviriyapan V
World J Gastroenterol; 2010 May; 16(19):2362-70. PubMed ID: 20480521
[TBL] [Abstract][Full Text] [Related]
12. Redox Proteomic Profile of Tirapazamine-Resistant Murine Hepatoma Cells.
Nemeikaitė-Čėnienė A; Haberkant P; Kučiauskas D; Stein F; Čėnas N
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047836
[TBL] [Abstract][Full Text] [Related]
13. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
14. Antiplasmodial Activity of Nitroaromatic Compounds: Correlation with Their Reduction Potential and Inhibitory Action on
Marozienė A; Lesanavičius M; Davioud-Charvet E; Aliverti A; Grellier P; Šarlauskas J; Čėnas N
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835450
[TBL] [Abstract][Full Text] [Related]
15. Reduction of nitroaromatic compounds by NAD(P)H:quinone oxidoreductase (NQO1): the role of electron-accepting potency and structural parameters in the substrate specificity.
Miseviciene L; Anusevicius Z; Sarlauskas J; Cenas N
Acta Biochim Pol; 2006; 53(3):569-76. PubMed ID: 16929382
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
[TBL] [Abstract][Full Text] [Related]
17. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
Jaiswal AK
Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
[TBL] [Abstract][Full Text] [Related]
18. Covalent inhibition of P. falciparum ferredoxin-NADP
de Rosa M; Nonnis S; Aliverti A
Biochem Biophys Res Commun; 2021 Nov; 577():89-94. PubMed ID: 34509083
[TBL] [Abstract][Full Text] [Related]
19. Redox properties and prooxidant cytotoxicity of a neuroleptic agent 6,7-dinitrodihydroquinoxaline-2,3-dione (DNQX).
Šarlauskas J; Nemeikaitė-Čėnienė A; Misevičienė L; Krikštopaitis K; Anusevičius Ž; Čėnas N
Acta Biochim Pol; 2013; 60(2):227-31. PubMed ID: 23757451
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
Han Y; Shen H; Carr BI; Wipf P; Lazo JS; Pan SS
J Pharmacol Exp Ther; 2004 Apr; 309(1):64-70. PubMed ID: 14718602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
